Magnetic nanoparticle hyperthermia for prostate cancer

Area of Science:

• Oncology
• Biomedical Engineering
• Nanotechnology

Background:

• Magnetic nanoparticles (MNPs) are utilized in clinical settings for drug delivery, MRI, and hyperthermia.
• Interstitial heating of tumors via direct MNP injection is a novel therapeutic approach.
• Prostate cancer treatment has explored this method in Phase I clinical trials.

Purpose of the Study:

• To evaluate the feasibility and tolerability of magnetic nanoparticle thermotherapy for prostate cancer.
• To validate a new method for planning and non-invasive thermal monitoring using CT.
• To assess the potential of MNPs in combination with brachytherapy.

Main Methods:

• Two Phase I clinical studies were conducted.
• Magnetic nanoparticle thermotherapy was administered alone and with brachytherapy.
• A novel CT-based method was used for planning and calculating 3D temperature distribution.

Main Results:

• The treatment demonstrated feasibility and good tolerability in both trials.
• A prototype alternating magnetic field applicator was used.
• The planning and thermal monitoring method was validated.

Conclusions:

• Magnetic nanoparticle thermotherapy is a feasible and tolerable option for localized prostate cancer.
• Current limitations include patient discomfort and irregular heat distribution.
• Combination therapy with irradiation is being evaluated pending further improvements.